SLC2A1 and Alzheimer disease: Importantly, these changes in glucose metabolism, possibly caused by abnormal Glut levels and reduced glycolytic flux, have been shown to contribute to the pathogenesis of AD (Ding et al., 2013; Sonntag et al., 2017).